HER2 NEGATIVE BREAST CARCINOMA
Clinical trials for HER2 NEGATIVE BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HER2 NEGATIVE BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for HER2 NEGATIVE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major trial aims to spare breast cancer patients from chemotherapy
Disease control Not yet recruitingThis large, Phase 3 trial is testing if a gentler treatment plan works as well as a stronger one for a specific type of breast cancer. It will enroll nearly 2,000 postmenopausal women and men with high-stage, hormone-sensitive, HER2-negative breast cancer that has a low genetic r…
Matched conditions: HER2 NEGATIVE BREAST CARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Scientists test radiation boost to supercharge immune attack on tough breast cancer
Disease control Not yet recruitingThis study aims to find the best dose of radiation to combine with standard chemotherapy and immunotherapy before surgery for an aggressive type of breast cancer that has spread to lymph nodes. It will enroll 32 patients who will be randomly assigned to receive either a low or hi…
Matched conditions: HER2 NEGATIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 09, 2026 14:25 UTC